Side-by-side comparison of AI visibility scores, market position, and capabilities
Zing Coach uses computer vision for real-time workout form feedback via smartphone; 2.5M+ users in 180 countries, 0M Series A. Founded 2020, Munich. Bridges passive video and live coaching.
Zing Coach was founded in 2020 in Munich, Germany, with the mission of making personalized fitness coaching accessible to everyone through AI. The company developed a computer vision-based coaching engine that analyzes movement in real time using a smartphone camera, providing form feedback and adaptive workout guidance without the need for wearables or gym equipment. This approach gave Zing Coach a technical differentiation in a crowded fitness app market.\n\nThe Zing Coach app offers AI-generated workout plans, real-time form analysis using pose estimation, progress tracking, and coaching feedback that adapts based on user performance and feedback. It targets users who want structured, corrective fitness guidance at home — positioning itself between passive workout video apps and expensive personal training. The platform supports a wide range of strength, mobility, and functional training programs across experience levels.\n\nZing Coach raised a $10M Series A and has grown to 2.5M+ users across 180 countries, demonstrating strong organic international demand. The company's real-time computer vision technology is a core moat, as it requires significant ML infrastructure investment that most fitness apps have not replicated. Founded and based in Munich, Zing Coach represents a new category of AI fitness tools that deliver coaching-quality feedback at consumer app scale.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.